Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2939 (LINC02939)

Target
LINC02939
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA), Other
01

Overview

Long intergenic non-protein coding RNA 2939 (LINC02939) is a gene that encodes a long intergenic non-coding RNA transcript, which does not overlap annotated coding genes and does not encode a protein[1][3]. LINC02939 is part of the lincRNA molecular class, distinguished by its regulatory functions in chromatin structure, gene expression, and possibly enhancer activity, although the specific cellular functions and disease associations of LINC02939 remain uncharacterized[1][3][5]. LincRNAs, in general, play important roles in fine-tuning expression of neighboring genes, modulating nuclear architecture, scaffolding protein complexes, and participating in RNA stabilization and transcriptional regulation across diverse cellular contexts[3][5]. There is no evidence that LINC02939 is currently considered a therapeutic target, nor are there any known interacting drugs or noted roles in human disease, according to current databases and scientific literature[1][3].\n\nIf more specific function or disease association data emerges, these fields may be updated accordingly.

02

Biological functions

Chromatin remodelingGenome architectureRNA stabilizationTranscription regulationEnhancer-associated activity
03

Disease associations

Other

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2939 (LINC02939).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2939 (LINC02939).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call